1,048
Views
7
CrossRef citations to date
0
Altmetric
Editorials

Parents’ perceptions of the HPV vaccine: a key target for improving immunization rates

, &
Pages 791-793 | Published online: 10 Jan 2014

References

  • Centers for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13–17 years – United States, 2011. MMWR Morb. Mortal. Wkly Rep. 61(34), 671–677 (2012).
  • Markowitz LE, Dunne EF, Saraiya M et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 56(RR-2), 1–24 (2007).
  • Centers for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly. Rep. 59(20), 626–629 (2010).
  • Klein NP, Hansen J, Chao C et al. Safety of quadrivalent human papillomavirus vaccine administered routinely to females. Arch. Pediat. Adol. Med. 166(12), 1140–1148 (2012).
  • Darden PM, Thompson DM, Roberts JR et al. Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008–2010. Pediatrics 131(4), 645–651 (2013).
  • Tan W, Viera AJ, Rowe-West B, Grimshaw A, Quinn B, Walter EB. The HPV vaccine: are dosing recommendations being followed? Vaccine 29(14), 2548–2554 (2011).
  • Martinez G, Copen CE, Abma JC. Teenagers in the United States: Sexual activity, contraceptive use, and childbearing, 2006–2010 national survey of family growth. Vital. Health Stat. 23(31), 1–35 (2011).
  • Slade BA, Leidel L, Vellozzi C et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 302(7), 750–757 (2009).
  • Kroger AT, Sumaya CV, Pickering LK, Atkinson WL. General recommendations on immunization – recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 60(2), 1–64 (2011).
  • Souayah N, Michas-Martin PA, Nasar A et al. Guillain–Barre syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006–2009. Vaccine 29(5), 886–889 (2011).
  • Slade BA, Gee J, Broder KR, Vellozzi C. Comment on the contribution by Souayah et al. ‘Guillain–Barre syndrome after Gardasil vaccination: data from vaccine adverse event reporting system 2006–2009’. Vaccine 29(5), 865–866 (2011).
  • Committee to Review Adverse Effects of Vaccines, Institute of Medicine. Adverse Effects of Vaccines: Evidence and Causality. Stratton, K, Ford, A, Rusch, E, Clayton, EW ( Eds). The National Academies Press, Washington, DC, USA (2012).
  • Bednarczyk RA, Davis R, Ault K, Orenstein W, Omer SB. Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds. Pediatrics 130(5), 798–805 (2012).
  • Liddon NC, Leichliter JS, Markowitz LE. Human papillomavirus vaccine and sexual behavior among adolescent and young women. Am. J. Prev. Med. 42(1), 44–52 (2012).
  • Benin AL, Wisler-Scher DJ, Colson E, Shapiro ED, Holmboe ES. Qualitative analysis of mothers’ decision-making about vaccines for infants: the importance of trust. Pediatrics 117(5), 1532–1541 (2006).
  • Salmon DA, Moulton LH, Omer SB, DeHart MP, Stokley S, Halsey NA. Factors associated with refusal of childhood vaccines among parents of school-aged children: a case–control study. Arch. Pediat. Adol. Med. 159(5), 470–476 (2005).
  • Jacobson RM, Van Etta L, Bahta L. The C.A.S.E. approach: Guidance for talking to vaccine-hesitant parents. Minn. Med. 96(4), 49–50 (2013).
  • Kharbanda EO, Stockwell MS, Fox HW, Andres R, Lara M, Rickert VI. Text message reminders to promote human papillomavirus vaccination. Vaccine 29(14), 2537–2541 (2011).
  • Szilagyi PG, Humiston SG, Gallivan S, Albertin C, Sandler M, Blumkin A. Effectiveness of a citywide patient immunization navigator program on improving adolescent immunizations and preventive care visit rates. Arch. Pediat. Adol. Med. 165(6), 547–553 (2011).
  • Brunson EK. The impact of social networks on parents’ vaccination decisions. Pediatrics 131(5), e1397–e1404 (2013).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.